Intervention Review

You have free access to this content

Selective serotonin reuptake inhibitors for premenstrual syndrome

  1. Jane Marjoribanks1,
  2. Julie Brown1,*,
  3. Patrick Michael Shaughn O'Brien2,
  4. Katrina Wyatt3

Editorial Group: Cochrane Menstrual Disorders and Subfertility Group

Published Online: 7 JUN 2013

Assessed as up-to-date: 11 FEB 2013

DOI: 10.1002/14651858.CD001396.pub3

How to Cite

Marjoribanks J, Brown J, O'Brien PMS, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD001396. DOI: 10.1002/14651858.CD001396.pub3.

Author Information

  1. 1

    University of Auckland, Obstetrics and Gynaecology, Auckland, New Zealand

  2. 2

    Keele University Medical School, Academic Department of Obstetrics and Gynaecology, Stoke-on-Trent, Staffordshire, UK

  3. 3

    Peninsula College of Medicine and Dentistry, Institute of Health Service Research, Exeter, UK

*Julie Brown, Obstetrics and Gynaecology, University of Auckland, Park Rd, Grafton, Auckland, 1003, New Zealand.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 JUN 2013


Cited in:


This article has been cited by:

  1. 1
    Adam J. Devall, Julia M. Santos, Jonathan P. Fry, John W. Honour, Marcus L. Brandão, Thelma A. Lovick, Elevation of brain allopregnanolone rather than 5-HT release by short term, low dose fluoxetine treatment prevents the estrous cycle-linked increase in stress sensitivity in female rats, European Neuropsychopharmacology, 2015, 25, 1, 113


  2. 2
    J P Fry, K Y Li, A J Devall, S Cockcroft, J W Honour, T A Lovick, Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase, British Journal of Pharmacology, 2014, 171, 24